Search Results
Dr. Choi on Frontline Treatment Considerations in CLL
Dr. Choi on Treatment Decisions in Relapsed/Refractory CLL
Selecting the Optimal Frontline Therapy in CLL
Evaluating Pharmacologic Agents in Relapsed/Refractory CLL
Approaching Therapy for Relapsed/Refractory CLL
Treatment sequencing options for recurrent CLL
Update on Venetoclax for CLL
Current Regimens Being Investigated in Chronic Lymphocytic Leukemia
#CIRMSymposium: Clinical Observations from the Phase 1 Trial of Cirmtuzumab - Michael Choi
Clinical updates for guadecitabine and vorinostat
The future in multiple myeloma: BiTE immunotherapy, CAR-T, and immune checkpoint inhibitors
Debate: Optimal approach for the management of CLL patients with del(17p) - Novel Agents
